Pulmatrix Inc - fluxo de caixa trimestral (NASDAQ:PULM) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Cash from operating activities -1.26 M-1.81 M-1.88 M-1.03 M-706 K -5.43 M Cash from investing activities 00000 0 Cash from financing activities 0———— — Free cash flow -1.26 M-1.81 M-1.88 M-1.03 M-706 K -5.43 M

Notícias

Pulmatrix adquire Eos SENOLYTIX em acordo de US$ 19 milhões focado em antienvelhecimento

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.15%

E.U.A. - Ações fecharam o pregão inalteradas e o Índice Dow Jones Industrial Average recuou 0,15%

Pulmatrix merger with Cullgen terminated by Chinese firm

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.38%

E.U.A. - Ações fecharam o pregão em alta e o Índice Dow Jones Industrial Average avançou 0,38%

Pulmatrix and Cullgen waive exclusivity while awaiting China approval

Kala Bio appoints Todd Bazemore as CEO and director, updates compensation

Pulmatrix (PULM) Q2 Revenue Falls 100%

Pulmatrix set for merger with Cullgen, seeks asset divestment